Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Aquaculture Vaccines Market

Aquaculture Vaccines Market Analysis

  • Report ID: GMI3323
  • Published Date: Mar 2023
  • Report Format: PDF

Aquaculture Vaccines Market Analysis

Based on type of vaccines, the aquaculture vaccines market is segmented as Inactivated vaccine, Live vaccine, and others. The inactive vaccines segment is expected to reach around USD 362.1 million by 2032. Antibiotics and probiotics appear to be less effective when novel mutant strains emerge, and disease-causing microorganisms gain resistance to routinely used antibiotics. Therefore, as a result, vaccinations produced using reducing molecular methods can be viewed as an effective method of treating disease-causing in aquatic creatures and assist to boost immunity to a particular disease or group of infections.

Global Aquaculture Market ,By Route Of Administration 2022-2032 (USD Millions))

Based on Route of Administration, aquaculture vaccines market is segmented as Immersion vaccines, Injection vaccines, Oral vaccines, and others. The Injection vaccines segment accounted for around USD 139.1 million in 2022. Injection vaccines are an efficient method of eliciting an antibody response in fish. The injection might be intramuscular or intraperitoneal. Most aquaculture vaccinations defend against bacterial infections. They can be taken through injections or oral intake (intraperitoneal or intramuscular).

Based on application, the aquaculture vaccines market is segmented as Bacterial infection, Viral infection, and others. The bacterial infection segment is estimated to show a lucrative CAGR of over 7.5% from 2023 to 2032. A bacterial infection develops when germs enter the body, multiply, and induce a response. In aquatic creatures, disease-causing microorganisms can be effectively treated using vaccines created techniques are effective, advanced molecular technology, which are cost effective.

Global Aquaculture Vaccines Market Share By Species

Norway aquaculture vaccines market is anticipated to reach more than USD 96.16 million by 2032. The significant market share is owing to several factors including presence of major market players, an increase in the demand for Aquaculture Vaccines, and increasing supply chain for the vaccines. Several market players in the region are engaged in new product development & commercialization that facilitates the Aquaculture Vaccines industrial expansion in the region.

In January 2023, ScaleAQ collaborated with fish vaccination specialist Skala Maskon by this the firm intends to broaden its value chain to become a whole supplier and partner to the farming sector. This is a strategic and significant purchase that brings together a diversified and robust expertise environment within the aquaculture sector's supply business. It will boost the company's position as a holistic supplier of vital infrastructure for the agricultural industry. Thus, the above-mentioned factors are projected to boost the European Aquaculture Vaccines industry growth during the analysis timeframe.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for aquaculture vaccines reached over USD 214.5 million in 2022 and is projected to expand at over 7.5% CAGR from 2023-2032.

Viral infections is estimated to reach over USD 72 million by the end of 2032 due to growing incidences of infectious pancreatic necrosis virus.

Europe aquaculture vaccines market size is expected to surpass USD 203.5 million by 2032 driven by an increasing number of fish farming initiatives and R&D activities.

Zoetis Inc., Merck & Co., Inc., HIPRA, Tecnovax, Virbac, Veterquimica S.A, and Nisseiken Co. Ltd. are some of the major manufacturers of aquaculture vaccines worldwide.

Aquaculture Vaccines Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 278
  • Countries covered: 22
  • Pages: 170
 Download Free Sample